Published in J Cell Biol on July 01, 1990
Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair. Mol Biol Cell (1993) 3.17
Production of transforming growth factor beta 1 during repair of arterial injury. J Clin Invest (1991) 2.70
PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol (1990) 2.26
Direct transfer of transforming growth factor beta 1 gene into arteries stimulates fibrocellular hyperplasia. Proc Natl Acad Sci U S A (1993) 2.03
Blockade of type beta transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proc Natl Acad Sci U S A (1999) 1.95
Multiple autocrine growth factors modulate vascular smooth muscle cell growth response to angiotensin II. J Clin Invest (1993) 1.66
Spatial and temporal patterns of immunoreactive transforming growth factor beta 1, beta 2, and beta 3 during excisional wound repair. Am J Pathol (1993) 1.52
Interstitial fibrosis and growth factors. Environ Health Perspect (2000) 1.32
TGF-beta1 increases proliferation of airway smooth muscle cells by phosphorylation of map kinases. Respir Res (2006) 1.26
Intimal smooth muscle cell proliferation after balloon catheter injury. The role of basic fibroblast growth factor. Am J Pathol (1992) 1.12
Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood (2006) 1.11
Elimination of smooth muscle cells in experimental restenosis: targeting of fibroblast growth factor receptors. Proc Natl Acad Sci U S A (1992) 1.09
Interaction of monocytes with cocultures of human aortic wall cells involves interleukins 1 and 6 with marked increases in connexin43 message. J Clin Invest (1991) 1.02
TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms. J Clin Invest (1994) 0.99
TGF-beta suppresses the upregulation of MMP-2 by vascular smooth muscle cells in response to PDGF-BB. Am J Physiol Cell Physiol (2009) 0.95
Peroxisome proliferator-activated receptor gamma (PPARγ) regulates thrombospondin-1 and Nox4 expression in hypoxia-induced human pulmonary artery smooth muscle cell proliferation. Pulm Circ (2012) 0.87
Evidence for an age-related dysfunction in the antiproliferative response to transforming growth factor-beta in vascular smooth muscle cells. Mol Biol Cell (1993) 0.86
Transforming growth factor β inhibits platelet derived growth factor-induced vascular smooth muscle cell proliferation via Akt-independent, Smad-mediated cyclin D1 downregulation. PLoS One (2013) 0.83
Aligned electrospun scaffolds and elastogenic factors for vascular cell-mediated elastic matrix assembly. J Tissue Eng Regen Med (2011) 0.82
Cytokines and growth factors promote airway smooth muscle cell proliferation. ISRN Inflamm (2012) 0.81
Growth factor expression during rat development: a comparison of TGF-beta 3, TGF-alpha, bFGF, PDGF and PDGF-R. Int J Exp Pathol (1993) 0.78
Inhibition of Epac1 suppresses mitochondrial fission and reduces neointima formation induced by vascular injury. Sci Rep (2016) 0.76
The distribution of PDGFs and PDGF-receptors during murine secondary palate development. J Anat (1995) 0.75
TGF-β-target genes are differentially regulated in corneal epithelial cells and fibroblasts. New Front Ophthalmol (2017) 0.75
The pathogenesis of atherosclerosis--an update. N Engl J Med (1986) 14.59
Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci U S A (1986) 12.14
Transforming growth factor-beta in human platelets. Identification of a major storage site, purification, and characterization. J Biol Chem (1983) 9.32
The biology of platelet-derived growth factor. Cell (1986) 7.17
Some recent advances in the chemistry and biology of transforming growth factor-beta. J Cell Biol (1987) 5.25
Transforming growth factor-beta: biological function and chemical structure. Science (1986) 5.08
Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells. J Cell Biol (1986) 3.77
An activated form of transforming growth factor beta is produced by cocultures of endothelial cells and pericytes. Proc Natl Acad Sci U S A (1989) 3.65
Two classes of PDGF receptor recognize different isoforms of PDGF. Science (1988) 3.59
Platelet-derived growth factor. I. High yield purification and evidence for multiple forms. J Biol Chem (1982) 3.35
Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem (1987) 3.25
Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types. EMBO J (1988) 3.16
Induction of c-sis mRNA and activity similar to platelet-derived growth factor by transforming growth factor beta: a proposed model for indirect mitogenesis involving autocrine activity. Proc Natl Acad Sci U S A (1986) 3.04
Replication of smooth muscle cells in vascular disease. Circ Res (1986) 2.98
Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science (1989) 2.98
The TGF-beta family of growth and differentiation factors. Cell (1987) 2.86
Correlation of procollagen mRNA levels in normal and transformed chick embryo fibroblasts with different rates of procollagen synthesis. Biochemistry (1978) 2.85
Transforming growth factor beta increases mRNA for matrix proteins both in the presence and in the absence of changes in mRNA stability. Proc Natl Acad Sci U S A (1988) 2.73
Control of smooth muscle cell growth by components of the extracellular matrix: autocrine role for thrombospondin. Proc Natl Acad Sci U S A (1986) 2.10
Platelet-derived growth factor and heparin-like glycosaminoglycans regulate thrombospondin synthesis and deposition in the matrix by smooth muscle cells. J Cell Biol (1985) 2.05
Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol (1988) 1.94
Expression and developmental control of platelet-derived growth factor A-chain and B-chain/Sis genes in rat aortic smooth muscle cells. Proc Natl Acad Sci U S A (1988) 1.92
Production of platelet-derived growth factor-like mitogen by smooth-muscle cells from human atheroma. N Engl J Med (1988) 1.79
Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem (1989) 1.79
A major part of platelet-derived growth factor purified from human platelets is a heterodimer of one A and one B chain. J Biol Chem (1988) 1.73
Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein. Proc Natl Acad Sci U S A (1986) 1.62
Induction of thrombospondin messenger RNA levels occurs as an immediate primary response to platelet-derived growth factor. J Biol Chem (1987) 1.62
Beta-type transforming growth factor specifies organizational behavior in vascular smooth muscle cell cultures. J Cell Biol (1987) 1.48
Growth factor expression in aorta of normotensive and hypertensive rats. J Clin Invest (1989) 1.46
Biological and biochemical properties of fibroblast growth factors. Implications for the pathogenesis of atherosclerosis. Arteriosclerosis (1989) 1.45
Methods for studying the platelet-derived growth factor receptor. Methods Enzymol (1985) 1.40
Mechanisms of arterial graft failure. 1. Role of cellular proliferation in early healing of PTFE prostheses. Am J Pathol (1985) 1.40
TGF-beta stimulates primary human skin fibroblast DNA synthesis via an autocrine production of PDGF-related peptides. J Cell Physiol (1989) 1.33
Carotid artery stenosis following endarterectomy. Arch Surg (1982) 1.30
Agents that increase cAMP accumulation block endothelial c-sis induction by thrombin and transforming growth factor-beta. J Biol Chem (1987) 1.26
Platelet-derived growth factor: three isoforms and two receptor types. Trends Genet (1989) 1.20
Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner. J Cell Biol (1988) 1.17
Vascular smooth muscle cells express distinct transforming growth factor-beta receptor phenotypes as a function of cell density in culture. J Biol Chem (1989) 1.15
Regulated expression of the platelet-derived growth factor A chain gene in microvascular endothelial cells. J Biol Chem (1987) 1.12
Partial amino acid sequence of human thrombospondin as determined by analysis of cDNA clones: homology to malarial circumsporozoite proteins. Biochemistry (1986) 1.10
Inhibition of normal rat kidney cell growth by transforming growth factor-beta is mediated by collagen. J Biol Chem (1989) 1.04
Regulation of platelet-derived growth factor gene expression by transforming growth factor beta and phorbol ester in human leukemia cell lines. Mol Cell Biol (1987) 0.90
Extracellular matrix: differential influence on growth and biosynthesis patterns of vascular smooth muscle cells from SHR and WKY rats. J Cell Physiol (1989) 0.88
Activation of S6 kinase in cultured vascular smooth muscle cells by submitogenic levels of thrombospondin. Biochem Biophys Res Commun (1988) 0.80
Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J Clin Invest (2001) 7.20
A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog (1993) 2.99
Cleavage of interleukin 1 beta (IL-1 beta) precursor to produce active IL-1 beta by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci U S A (1993) 2.92
Expression of smooth muscle cell phenotype by rat mesangial cells in immune complex nephritis. Alpha-smooth muscle actin is a marker of mesangial cell proliferation. J Clin Invest (1991) 2.58
Developmental mechanisms underlying pathology of arteries. Physiol Rev (1990) 2.17
Cell surface thrombospondin is functionally essential for vascular smooth muscle cell proliferation. J Cell Biol (1988) 1.94
Role of platelets in smooth muscle cell proliferation and migration after vascular injury in rat carotid artery. Proc Natl Acad Sci U S A (1989) 1.74
Reconstitution of hair follicle development in vivo: determination of follicle formation, hair growth, and hair quality by dermal cells. J Invest Dermatol (1993) 1.66
A role for serum response factor in coronary smooth muscle differentiation from proepicardial cells. Development (1999) 1.62
Coronary smooth muscle differentiation from proepicardial cells requires rhoA-mediated actin reorganization and p160 rho-kinase activity. Dev Biol (2001) 1.37
Heparin regulates smooth muscle S phase entry in the injured rat carotid artery. Circ Res (1987) 1.24
Stem cell plasticity in muscle and bone marrow. Ann N Y Acad Sci (2001) 1.21
Dominant negative murine serum response factor: alternative splicing within the activation domain inhibits transactivation of serum response factor binding targets. Mol Cell Biol (1999) 1.17
Expression of apolipoprotein E by cultured vascular smooth muscle cells is controlled by growth state. J Cell Biol (1988) 1.07
Retinoid receptor expression and all-trans retinoic acid-mediated growth inhibition in vascular smooth muscle cells. Circulation (1996) 1.01
Focal smooth muscle proliferation in the aortic intima produced by an initiation-promotion sequence. Proc Natl Acad Sci U S A (1985) 0.94
Developmentally regulated cytochrome P-450IA1 expression in cultured rat vascular smooth muscle cells. J Biol Chem (1991) 0.92
The intima: development and monoclonal responses to injury. Atherosclerosis (1995) 0.91
Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells. Circ Res (1992) 0.89
Carcinogenesis and atherogenesis: differences in monooxygenase inducibility and bioactivation of benzo[a]pyrene in aortic and hepatic tissues of atherosclerosis-susceptible versus resistant pigeons. Carcinogenesis (1983) 0.88
An origin for smooth muscle cells from endothelium? Circ Res (1997) 0.86
Synthesis of a series of stromelysin-selective thiadiazole urea matrix metalloproteinase inhibitors. J Med Chem (1999) 0.85
A little VEGF goes a long way. Therapeutic angiogenesis by direct injection of vascular endothelial growth factor-encoding plasmid DNA. Circulation (1996) 0.84
Metabolism of benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene in chicken aortas: monooxygenation, bioactivation to mutagens, and covalent binding to DNA in vitro. Toxicol Appl Pharmacol (1980) 0.83
Signal transduction pathways modulated by D2-like dopamine receptors. Adv Pharmacol (1998) 0.83
Cell cycle regulators in vascular disease. Circulation (1997) 0.78
Novel genes for mitogen-independent smooth muscle replication. Circ Res (2000) 0.77
Postnatal regulation of fibroblast growth factor ligand and receptor gene expression in rat thoracic aorta. Am J Pathol (1996) 0.75
A Bill of Rights for the handicapped. Am Educ (1976) 0.75
Interaction of alpha and beta adrenergic stimulation on aortic ornithine decarboxylase activity. Life Sci (1985) 0.75
Phase II biotransformation of carcinogens/atherogens in cultured aortic tissues and cells. II. Glucuronidation of 3-hydroxy-benzo(a)pyrene. Drug Metab Dispos (1986) 0.75
Elicitation of raised aortic smooth muscle lesions with an initiation-promotion regimen. Dev Toxicol Environ Sci (1983) 0.75
Serum oxytocinase levels. A laboratory and clinical appraisal. Am J Obstet Gynecol (1974) 0.75
Tenascin is synthesized and secreted by rat mesangial cells in culture and is present in extracellular matrix in human glomerular diseases. J Am Soc Nephrol (1994) 0.75